SIEGALL CLAY B bought IMNM
December 19, 2025 · Form 4 insider transaction
SIEGALL CLAY B bought 7,278 shares of Immunome, Inc. at $20.48 per share, a transaction worth $149.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,278
Price
$20.48
Total value
$149.1K
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 19, 2025
Filing dateDecember 22, 2025
Shares owned after860,525
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The weighted average purchase price for the transaction report was $20.48, and the range of prices were between $20.36 and $20.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.